Sex hormones, lipid and carbohydrate metabolism



The marked difference in incidence of atherosclerosis in males and females, at least in developed countries, has prompted a search for differences in risk factors between the two sexes. Most attention has been paid to plasma lipids and lipoproteins and many epidemiological studies have reported differences in total and individual lipoprotein cholesterol and triglyceride in males and females.


Oral Contraceptive Plasma Lipid Hepatic Lipase Oral Contraceptive User Ethinyl Oestradiol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lipid Research Clinics Program Epidemiology Committee (1979). Plasma lipid distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation, 60, 427Google Scholar
  2. 2.
    Carlson, L. A. and Lindsted, S. (1969). The Stockholm Prospective Study. I. The initial values for plasma lipids. Acta Med. Scand., 185, (suppl. 493), 1Google Scholar
  3. 3.
    Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L. and Motulsky, A. G. (1973). Hyperlipidemia in coronary heart disease. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest., 52, 1533PubMedCrossRefGoogle Scholar
  4. 4.
    Lewis, B., Chait, A., Wooton, I. D. P. et al. (1974). Frequency of risk factors for ischaemic heart-disease in a healthy British population. Lancet, 1, 141PubMedCrossRefGoogle Scholar
  5. 5.
    Dyerberg, J. and Hjorne, N. (1973). Plasma lipid and lipoprotein levels in childhood and adolescence. Scand. J. Clin. Lab. Invest., 31, 473PubMedCrossRefGoogle Scholar
  6. 6.
    Nikkila, E. A. and Kekki, M. (1971). Polymorphism of plasma triglyceride kinetics in normal human adult subjects. Acta Med. Scand., 190, 49PubMedCrossRefGoogle Scholar
  7. 7.
    Olefsky, J., Farquhar, J. W. and Reaven, G. M. (1974). Sex difference in kinetics of triglyceride metabolism in normal and hypertriglyceridaemic human subjects. Eur. J. Clin. Invest., 4, 121PubMedGoogle Scholar
  8. 8.
    Carlson, L. A. and Ericsson, M. (1975). Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women. Atherosclerosis, 21, 417PubMedCrossRefGoogle Scholar
  9. 9.
    Slack, J., Noble, N., Meade, T. W. and North, W. R. S. (1977). Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London. Br. Med. J., 2, 353PubMedCrossRefGoogle Scholar
  10. 10.
    Stern, M. P., Brown, B. W., Jr, Haskell, W. L., Farquhar, J. W., Wehrle, C. L. and Wood, P. D. S. (1976). Cardiovascular risk and use of oestrogens or oestrogen- progestogen combinations. J. Am. Med. Assoc., 235, 811CrossRefGoogle Scholar
  11. 11.
    Wallace, R. B., Hoover, J., Sandler, D., Rifkind, B. M. and Tyroler, H. A. (1977). Altered plasma lipids associated with oral contraceptive or oestrogen consumption. Lancet, 2, 11PubMedCrossRefGoogle Scholar
  12. 12.
    Wallace, R. B., Hoover, J., Barrett-Connor, E. et al. (1979). Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Lancet, 111, 655Google Scholar
  13. 13.
    Hennekens, C. H., Evans, D. A., Castelli, W. P., Taylor, J. O., Rosner, B. and Kass, E. H. (1979). Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol. Circulation, 60, 486PubMedGoogle Scholar
  14. 14.
    Miller, G. J. and Miller, N. E. (1975). Plasma-high density-lipoprotein concentration and development of ischaemic heart-disease. Lancet, 1, 16PubMedCrossRefGoogle Scholar
  15. 15.
    Albers, J. J., Wahl, P. W., Cabana, V. G., Hazzard, W. R. and Hoover, J. J. (1976). Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism, 25, 633PubMedCrossRefGoogle Scholar
  16. 16.
    Bradley, D. D., Wingerd, J., Petitti, D. A., Kraus, R. M. and Raucharan, S. (1978). Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestogens. N. Engl. J. Med., 299, 17PubMedCrossRefGoogle Scholar
  17. 17.
    Arntzenius, A. C., van Gent, C. M., van der Voort, H., Stegerhoek, C. I. and Styblo, K. (1978). Reduced high-density lipoprotein in women aged 40–41 using oral contraceptives. Lancet, 1, 1221PubMedCrossRefGoogle Scholar
  18. 18.
    Krauss, R. M., Lindgren, F. T., Silvers, A., Jutagir, R. and Bradley, D. D. (1977) Changes in serum high density lipoproteins in women on oral contraceptive drugs. Clin. Chim. Acta, 80, 465PubMedCrossRefGoogle Scholar
  19. 19.
    Larsson-Cohn, U., Wallentin, L. and Zador, G. (1979). Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Horm. Metab. Res., 11, 437PubMedCrossRefGoogle Scholar
  20. 20.
    Buckman, M. T., Johnson, J., Ellis, H., Srivastava, L. and Peake, G. T. (1980). Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate. Metabolism, 29, 803PubMedCrossRefGoogle Scholar
  21. 21.
    Wallentin, L. and Varenhorst, E. (1978). Changes of plasma lipid metabolism in males during estrogen treatment for prostatic carcinoma. J. Clin. Endocrinol. Metab., 47, 596PubMedCrossRefGoogle Scholar
  22. 22.
    Wallentin, L. and Varenhorst, E. (1981). Plasma lipoproteins during anti-androgen treatment by estrogens or orchidectomy in men with prostatic carcinoma. Horm. Metab. Res., 13, 293PubMedCrossRefGoogle Scholar
  23. 23.
    Nordoy, A., Aakvaag, A. and Thelle, D. (1979). Sex hormones and high density lipoproteins in healthy males. Atherosclerosis, 34, 431PubMedCrossRefGoogle Scholar
  24. 24.
    Heller, R. F., Miller, N. E., Lewis, B. et al. (1981) Associations between sex hormones, thyroid hormones and lipoproteins. Clin. Sci., 61, 649PubMedGoogle Scholar
  25. 25.
    Mendozza, S. G., Osuna, A., Zerpa, A., Gartside, P. S. and Glueck, C. J. (1981). Hypertriglyceridemia and hypoalphalipoproteinemia in azoospermic and oligospermic young men: relationships of endogenous testoterone to triglyceride and high density lipoprotein cholesterol metabolism. Metabolism, 30, 481CrossRefGoogle Scholar
  26. 26.
    Gutai, J., La Porte, R., Kuller, L., Dai, W., Falvo-Gerard, L. and Cagguila, A. (1981). Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am. J. Cardiol., 48, 897PubMedCrossRefGoogle Scholar
  27. 27.
    Reckless, J. P. D., Betteridge, D. J., Taylor, K. G. et al. (1980). Serum lipoproteins and the concentrations of thyroxine and sex hormones in diabetic man. Horm. Metab. Res., 12, 629PubMedCrossRefGoogle Scholar
  28. 28.
    Wynn, V., Adams, P. W., Godsland, I. et al. (1979). Comparison of effects of different combined oral contraceptive formulations on carbohydrate and lipid metabolism. Lancet, 1, 1045PubMedCrossRefGoogle Scholar
  29. 29.
    Taggart, H. and Stout, R. W. (1981). Effect of a low dose estrogen-progestogen oral contraceptive on lipids and lipoproteins. Irish J. Med. Sci., 150, 13PubMedCrossRefGoogle Scholar
  30. 30.
    Knopp, R. H., Walden, C. E., Wahl, P. W. et al. (1981). Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationship to estrogen and progestin potency. J. Clin. Endocrinol. Metab., 53, 1123PubMedCrossRefGoogle Scholar
  31. 31.
    Hirvonen, E., Malkonen, M. and Marninen, V. (1981). Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N. Engl. J. Med., 304, 560PubMedCrossRefGoogle Scholar
  32. 32.
    Glueck, C. J., Ford, S., Jr., Steiner, P. and Fallat, R. (1973). Triglyceride removal efficiency and lipoprotein lipases: effects of oxandrolone. Metabolism, 22, 807PubMedCrossRefGoogle Scholar
  33. 33.
    Solyom, A. (1972). Effect of androgens on serum lipids and lipoproteins. Lipids, 7, 100PubMedCrossRefGoogle Scholar
  34. 34.
    Ehnholm, C., Huttunen, J. K., Kinnunen, P. J., Miettinen, T. A. and Nikkila, E. A. (1975). Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1of human postheparin plasma. N. Engl. J. Med., 292, 1314PubMedCrossRefGoogle Scholar
  35. 35.
    Kissebah, A. H., Harrigan, P., Adams, P. W. and Wynn, V. (1973). Effect of methandienone on free fatty acid and triglyceride turnover in normal females. Horm. Metab. Res., 5, 275PubMedCrossRefGoogle Scholar
  36. 36.
    Bagdade, J. D., Livingston, R. and Yee, E. (1975). Effects of the synthetic androgen fluoxymesterone on triglyceride secretion rates in the rat. Proc. Soc. Exp. Biol. Med., 149, 452PubMedGoogle Scholar
  37. 37.
    Hazzard, W. R., Spiger, M. J., Bagdade, J. D. and Bierman, E. L. (1969). Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. N. Engl. J. Med., 280, 471PubMedCrossRefGoogle Scholar
  38. 38.
    Applebaum, D. M., Goldberg, A. P., Pykalisto, O. J., Brunzell, J. D. and Hazzard, W. R. (1977). Effect of estrogen on postheparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J. Clin. Invest., 59, 601PubMedCrossRefGoogle Scholar
  39. 39.
    Kekki, M. and Nikkila, E. A. (1971). Plasma triglyceride turnover during use of oral contraceptives. Metabolism, 20, 878PubMedCrossRefGoogle Scholar
  40. 40.
    Kissebah, A. H., Harrigan, P. and Wynn, V. (1973). Mechanism of hypertriglyceridaemia associated with contraceptive steroids. Horm. Metab. Res., 5, 184PubMedCrossRefGoogle Scholar
  41. 41.
    Rossner, S., Larsson-Cohn, H., Carlson, C. A. and Boherg, J. (1971). Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase-activity. Acta Med. Scand., 190, 301PubMedCrossRefGoogle Scholar
  42. 42.
    Chait, A., Brunzell, J. D., Albers, J. J. and Hazzard, W. R. (1977). Type III hyperlipoproteinaemia (‘remnant removal disease’). Lancet, 1, 1176PubMedCrossRefGoogle Scholar
  43. 43.
    Kushwaha, R. S., Hazzard, W. R., Gagne, C., Chait A. and Albers, J. J. (1977). Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogen. Ann. Intern. Med., 87, 517PubMedGoogle Scholar
  44. 44.
    Floren, C-H., Kushwaha, R. S., Hazzard, W. R. and Albers, J. J. (1981). Estrogen- induced increase in uptake of cholesterol rich very low density lipoproteins in perfused rabbit liver. Metabolism, 30, 367PubMedCrossRefGoogle Scholar
  45. 45.
    Wynn, V. and Doar, J. W. H. (1969). Some effects of oral contraceptives on carbohydrate metabolism. Lancet, 2, 761PubMedCrossRefGoogle Scholar
  46. 46.
    Wynn, V. and Doar, J. W. H. (1966). Some effects of oral contraceptives on carbohydrate metabolism. Lancet., 2, 715PubMedCrossRefGoogle Scholar
  47. 47.
    Spellacy, W. N., Buhi, W. C., Spellacy, C. E., Moses, L. E. and Goldzieher, J. W. (1970). Glucose, insulin and growth hormone studies in long-term users of oral contraceptives. Am. J. Obstet. Gynecol., 106, 173PubMedGoogle Scholar
  48. 48.
    Ashby, J. P., Shirling, D. and Baird, J. D. (1981). Effect of progestogen on the secretion and peripheral action of insulin and glucagon in the intact rat. J. Endocrinol., 88, 49PubMedCrossRefGoogle Scholar
  49. 49.
    Leis, D., Bottermann, P., Ermler, R. and Schlauch, W. (1980). Effects of low-dose gestagen and combination-type oral contraception on blood glucose and serum insulin levels after a glucose load. Arch. Gynecol., 230, 143PubMedCrossRefGoogle Scholar
  50. 50.
    Barrett-Connor, E., Brown, W. V., Turner, J., Austin, M. and Criqui, M. H. (1979). Heart disease risk factors and hormone use in postmenopausal woman. J. Am. Med. Assoc., 241, 2167CrossRefGoogle Scholar
  51. 51.
    Ostrander, L. D., Lamphiear, D. E., Block, W. D., Williams, G. W. and Carmen, W. J. (1980). Oral contraceptives and physiological variables. J. Am. Med. Assoc., 244, 677CrossRefGoogle Scholar

Copyright information

© R. W. Stout 1982

Authors and Affiliations

  1. 1.The Queen’s University of BelfastUK

Personalised recommendations